20.06.2011 • Videos

Thomas Gründemann of Ferak Berlin on Custom Synthesis Trends

Ferak Berlin CEO Thomas Grünemann took a few minutes at this year's Chemspec Europe in Geneva to talk to CHEManager Europe Editor-in-Chief Brandi Schuster about custom synthesis and his company's "one product per campaign" strategy.

Company

Ferak Berlin GmbH

Lahnstr. 34
12055 Berlin
Germany

Company contact







Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Top-Feature

most read